At the beginning of April, 2016, Minnesota based biotech Vascular Solutions, Inc. (NASDAQ:VASC) reported that it was withdrawing and recalling a large number of its lead product, its Guardian® II Hemostasis Valves, from the market. The recall came on the back of findings that suggested the product could leak,...
Aeglea Bio Therapeutics Inc (NASDAQ:AGLE), a Texas based development stage biotech company, just gave us an update regarding its intentions to report (present) data at an upcoming conference. The data, which relates to its early stage oncology candidate AEB1102, will hit press as part of a scientific poster session at...